๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease

โœ Scribed by Mark A. Bowman; Edward H. Leiter; Mark A. Atkinson

Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
804 KB
Volume
15
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The role of superantigens in human disea
The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases
โœ Leung; Hauk; Strickland; Travers; Norris ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 370 KB

Although it is well established that immune mechanisms contribute to the pathogenesis of chronic inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis, the actual events that trigger the immunological pathways resulting in these skin diseases are not well understood. Colonization a

Nicotinamide prevents the development of
Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis
โœ O'Brien, Bronwyn A.; Harmon, Brian V.; Cameron, Donald P.; Allan, David J. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 195 KB ๐Ÿ‘ 2 views

The development of diabetes in non-obese diabetic (NOD) mice, which normally takes between 3 and 7 months, can be accelerated by cyclophosphamide (CY) injections, with rapid progression to diabetes within only 2ยฑ3 weeks. This insulin-dependent diabetes mellitus (IDDM) can be prevented or delayed in